{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:20:51Z","timestamp":1791667251017,"version":"4.3.4"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:p>We report a series of 6 melanocytic proliferations harboring both <jats:italic toggle=\"yes\">NRAS<\/jats:italic> and <jats:italic toggle=\"yes\">IDH1<\/jats:italic> hotspot mutations. Clinically, there was no specific sex-ratio, ages ranged from 18 to 85 years, and the trunk and limbs were the most affected localizations. In half of the cases, progressive modification of a pre-existing nevus was reported. Morphologically, all tumors were predominantly based in the dermis and the most striking pathologic finding was the presence of a background architecture of congenital-type nevi with a superimposed biphasic pattern formed by dendritic pigmented melanocytes surrounding areas of nevoid melanocytes. This finding was further underscored by HMB45 staining, which was positive in the dendritic cells and negative in the nevoid melanocytes. Four cases displayed increased cellularity and 1 case showed increased dermal mitotic activity. DNA and RNA sequencing revealed <jats:italic toggle=\"yes\">NRAS<\/jats:italic>\n                           <jats:sup>\n                              Q61R\n                           <\/jats:sup> and <jats:italic toggle=\"yes\">IDH1<\/jats:italic>\n                           <jats:sup>\n                              R132C\n                           <\/jats:sup> comutations in all 6 cases, with homogenous expression data according to unsupervised clustering analysis. Array-comparative genomic hybridization revealed no copy number alteration for the 2 most cellular and mitogenic cases. All were surgically excised, available follow-up for 2 patients showed no relapse nor metastases. We hypothesize that the <jats:italic toggle=\"yes\">IDH1<\/jats:italic> mutation is a secondary event in a pre-existing <jats:italic toggle=\"yes\">NRAS<\/jats:italic>-mutated nevus and could be in part responsible for the emergence of a pigmented dendritic dermal component. So far, such comutations have been reported in one benign melanocytic nevus and several melanomas. This combination could represent a new subgroup of intermediate prognosis (melanocytoma) with a distinctive morphology. Further acquisition of genomic anomalies could progressively lead to malignant transformation.<\/jats:p>","DOI":"10.1097\/pas.0000000000001500","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T21:05:28Z","timestamp":1595624728000},"page":"1398-1405","source":"Crossref","is-referenced-by-count":13,"title":["Cutaneous Melanocytic Tumors With Concomitant NRAS Q61R and IDH1 R132C Mutations"],"prefix":"10.1097","volume":"44","author":[{"given":"Nicolas","family":"Macagno","sequence":"first","affiliation":[{"name":"APHM, Timone, Department of Pathology"},{"name":"INSERM, MMG, Aix Marseille University, Marseille"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pissaloux","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Centre Le\u0301on Be\u0301rard"},{"name":"INSERM 1052, CNRS 5286, Centre L\u00e9on B\u00e9rard, Cancer Research Center of Lyon, Equipe Labellis\u00e9e Ligue contre le Cancer, Universit\u00e9 de Lyon, Universit\u00e9 Claude Bernard Lyon 1, Lyon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Etchevers","sequence":"additional","affiliation":[{"name":"INSERM, MMG, Aix Marseille University, Marseille"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Haddad","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Centre Le\u0301on Be\u0301rard"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Vergier","sequence":"additional","affiliation":[{"name":"Pathology Department, H\u00f4pital Haut-L\u00e9v\u00eaque, University Hospital of Bordeaux, Bordeaux"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Sierra-Fortuny","sequence":"additional","affiliation":[{"name":"Cabinet de dermatologie, Le Mans, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Tirode","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Centre Le\u0301on Be\u0301rard"},{"name":"INSERM 1052, CNRS 5286, Centre L\u00e9on B\u00e9rard, Cancer Research Center of Lyon, Equipe Labellis\u00e9e Ligue contre le Cancer, Universit\u00e9 de Lyon, Universit\u00e9 Claude Bernard Lyon 1, Lyon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"de la Fouchardi\u00e8re","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Centre Le\u0301on Be\u0301rard"},{"name":"INSERM 1052, CNRS 5286, Centre L\u00e9on B\u00e9rard, Cancer Research Center of Lyon, Equipe Labellis\u00e9e Ligue contre le Cancer, Universit\u00e9 de Lyon, Universit\u00e9 Claude Bernard Lyon 1, Lyon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1158\/1078-0432.CCR-12-1773","article-title":"IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives","volume":"18","author":"Yang","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00401-009-0561-9","article-title":"Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas","volume":"118","author":"Hartmann","year":"2009","journal-title":"Acta Neuropathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1158\/1078-0432.CCR-08-1361","article-title":"CpG island methylator phenotype predicts progression of malignant melanoma","volume":"15","author":"Tanemura","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/neuonc\/nox183","article-title":"Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications","volume":"20","author":"Malta","year":"2018","journal-title":"Neuro Oncol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/his.13707","article-title":"Isocitrate dehydrogenase 1 mutations in melanoma frequently co-occur with NRAS mutations","volume":"73","author":"Linos","year":"2018","journal-title":"Histopathology"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/modpathol.2016.237","article-title":"Spitz nevi and Spitzoid melanomas: exome sequencing and comparison with conventional melanocytic nevi and melanomas","volume":"30","author":"Lazova","year":"2017","journal-title":"Mod Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/PAS.0b013e3182498be5","article-title":"A distinct subset of atypical spitz tumors is characterized by BRAF mutation and loss of BAP1 expression","volume":"36","author":"Wiesner","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41467-017-00758-3","article-title":"Combined activation of MAP kinase pathway and \u03b2-catenin signaling cause deep penetrating nevi","volume":"8","author":"Yeh","year":"2017","journal-title":"Nat Commun"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1097\/PAS.0b013e31822e9f5e","article-title":"Combined melanocytic nevi: histologic variants and melanoma mimics","volume":"35","author":"Baran","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N Engl J Med"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ajpath.2010.12.011","article-title":"Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation","volume":"178","author":"Shibata","year":"2011","journal-title":"Am J Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001500","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:59:12Z","timestamp":1695423552000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001500"}},"subtitle":["A Report of 6 Cases"],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001500","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,23]]}}}